INCUBATION OF LYMPHOCYTES WITH IL-2 CAUSES THE APPEARANCE OF ANTITUMOR T CELLS CARRYING FC, CD25 AND LFA-1 ON THE SURFACE

O. K. Ivanova; Иванова О. К.; T. N. Sharapova; Шарапова Т. Н.; E. A. Romanova; Романова Е. А.; D. V. Yashin; Яшин Д. В.; L. P. Sashchenko; Сащенко Л. П.

doi:10.31857/S2686738923700208

INCUBATION OF LYMPHOCYTES WITH IL-2 CAUSES THE APPEARANCE OF ANTITUMOR T CELLS CARRYING FC, CD25 AND LFA-1 ON THE SURFACE

Авторлар: Ivanova O.¹, Sharapova T.¹, Romanova E.¹, Yashin D.¹, Sashchenko L.¹
Мекемелер:
1. Institute of Gene Biology of the Russian Academy of Sciences
Шығарылым: Том 510, № 1 (2023)
Беттер: 225-230
Бөлім: Articles
URL: https://journals.rcsi.science/2686-7389/article/view/135687
DOI: https://doi.org/10.31857/S2686738923700208
EDN: https://elibrary.ru/QICODU
ID: 135687

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

To carry out antitumor activity against cells that have lost surface antigens, human lymphocytes must have a certain repertoire of surface proteins capable of contacting a tumor cell and inducing programmed cell death in it. In this work, we showed that activation of healthy donor cells by IL-2 cytokine within 6 days causes the appearance of FasL, CD25 and LFA-1 proteins on CD8⁺CD25⁺ T lymphocytes, and also converts the LFA-1 protein into an active form having a high affinity for its target, ICAM-1 integrin. The appearance of these proteins on the surface of this subpopulation of lymphocytes allows them to induce programmed cell death in HLA-negative tumor cells.

Негізгі сөздер

Tag7, integrins, FasL, IL-2, tumor cells

Әдебиет тізімі

Phillips J.H., et al. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. //J Exp Med. 1986. PMID: 3489062
Yannelli J.R. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer // J Immunol Methods. 1991. PMID: 2040807
Sharapova T.N., Romanova E.A., Ivanova O.K., et al. Cytokines TNFα, IFNγ and IL-2 are responsible for signal transmission from the innate immunity protein Tag7 (PGLYRP1) to cytotoxic effector lymphocytes // Cells. 2020. V. 9. № 12. P. 2602.
Sashchenko L.P., Romanova E.A., Ivanova O.K., et al. FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP-S-Hsp70 complex by the cytotoxic CD8+ lymphocytes // IUBMB Life. 2017. V. 69. № 1. P. 30–36.
Sharapova T.N., Ivanova O.K., Soshnikova N.V., et al. Innate immunity protein Tag7 induces 3 distinct populations of cytotoxic cells that use different mechanisms to exhibit their antitumor activity on human leukocyte antigen-deficient cancer cells // J. Innate Immun. 2017. V. 9. № 6. P. 598–608.
Ivanova O.K., Sharapova T.N., Romanova E.A., et al. CD3+ CD8+ NKG2D+ T lymphocytes induce apoptosis and necroptosis in HLA-negative cells via FasL-Fas interaction // J. Cell Biochem. 2017. Vol. 118, № 10. P. 3359–3366.
Davis D.M. and Dustin M.L. What is the importance of the immunological synapse? // Trends Immunol. 2004. V. 25. № 6. P. 323–327.
Walling B.L., Kim M. LFA-1 in T Cell Migration and Differentiation. // Front Immunol. 2018 May. V. 3. № 9. P. 952. doi: . eCollection 2018. PMID: 29774029 https://doi.org/10.3389/fimmu.2018.00952
Barber D.F., Faure M., Long E.O. LFA-1 contributes an early signal for NK cell cytotoxicity // J Immunol. 2004 Sep 15. V. 173. № 6. P. 3653–9. https://doi.org/10.4049/jimmunol.173.6.3653
Long E.O. ICAM-1: getting a grip on leukocyte adhesion // J. Immunol. 2011. V. 186. № 9. P. 5021–5023.
Kos F.J. and Chin C.S. Costimulation of T cell receptor-triggered IL-2 production by Jurkat T cells via fibroblast growth factor receptor 1 upon its engagement by CD56 // Immunol. Cell. Biol. 2002. V. 80. № 4. P. 364–369.
Wang Y., Li D., Nurieva R., et al. LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells. // J. Biol. Chem. 2009. V. 284. № 19. P. 12645–12653.